Mountain View, United States
CyberHeart, Inc., a pioneering company in the Health Care, Medical Devices, and Robotics industries, has carved out a unique niche in the treatment of cardiac arrhythmias. Founded in 2006, this United States-based firm leverages the innovative CyberKnife systems and technology, enabling minimally invasive, outpatient procedures.
The company's strategic direction is emphasized by its slogan: "Acquisition by a leader in radiosurgery...", hinting at a potential growth avenue through strategic alliances or acquisitions. CyberHeart's approach addresses a substantial healthcare need by introducing radiation-based solutions for heart rhythm disorders.
In terms of financials, CyberHeart, Inc. secured its last funding of $2.17M via a Series B investment on 15 February 2011. Although specific investors were not disclosed, this injection supports their ongoing innovations and market growth.
